Application 020680
- Type
- NDA
- Sponsor
- ABBOTT
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | NORVIR | RITONAVIR | CAPSULE;ORAL | 100MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N020680-001 | NORVIR | RITONAVIR | 100MG | CAPSULE / ORAL | 1996-03-01 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-10-28 04:53 UTC | 2022-10 | N020680-001 | NORVIR | 100MG | CAPSULE / ORAL | 1996-03-01 | f41ea6bd6efb… | ||
| 2022-09-29 23:25 UTC | 2022-09 | N020680-001 | NORVIR | 100MG | CAPSULE / ORAL | 1996-03-01 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N020680-001 | NORVIR | 100MG | CAPSULE / ORAL | 1996-03-01 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N020680-001 | NORVIR | 100MG | CAPSULE / ORAL | 1996-03-01 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ritonavir | RITONAVIR | Amneal Pharmaceuticals LLC | a32cb2e3-d4e5-4bbf-9d88-20b2b249e779 | 2026-08-06 | Boxed warning, Warnings, Adverse reactions | RITONAVIR |
| Norvir | RITONAVIR | AbbVie Inc. | 2849298e-de6e-47bb-8194-56e075b33fc3 | 2026-07-23 | Boxed warning, Warnings, Adverse reactions | Norvir RITONAVIR |
| Ritonavir | RITONAVIR | Bryant Ranch Prepack | d2f8c6ba-5e06-4b03-8ca5-b4fd7e5a8925 | 2026-03-11 | Boxed warning, Warnings, Adverse reactions | RITONAVIR |
| Ritonavir | RITONAVIR | NuCare Pharmaceuticals, Inc. | 3f92f1e2-59f4-f6c4-e063-6294a90a487b | 2025-09-24 | Boxed warning, Warnings, Adverse reactions | RITONAVIR |
| Ritonavir | RITONAVIR | Bryant Ranch Prepack | 3c811e3e-f685-4af7-a4d1-037f2613ee68 | 2025-06-05 | Boxed warning, Warnings, Adverse reactions | RITONAVIR |
| Ritonavir | RITONAVIR | American Health Packaging | 19503bc4-3443-4ad4-aa27-437f4f3288b1 | 2024-04-13 | Boxed warning, Warnings, Adverse reactions | RITONAVIR |
| Ritonavir | RITONAVIR | Camber Pharmaceuticals, Inc. | db633374-6d8e-4622-9fe1-f9d68baa59bb | 2023-02-22 | Boxed warning, Warnings, Adverse reactions | RITONAVIR |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.